0% found this document useful (0 votes)
8 views7 pages

Srep 19983

Uploaded by

Alexia Tanase
Copyright
© © All Rights Reserved
Available Formats
Download as PDF, TXT or read online on Scribd
Download as pdf or txt
0% found this document useful (0 votes)
8 views7 pages

Srep 19983

Uploaded by

Alexia Tanase
Copyright
© © All Rights Reserved
Available Formats
Download as PDF, TXT or read online on Scribd
Download as pdf or txt
Download as pdf or txt
You are on page 1/ 7

www.nature.

com/scientificreports

OPEN Robotic lower limb prosthesis


design through simultaneous
computer optimizations of human
received: 15 September 2015
accepted: 18 December 2015 and prosthesis costs
Published: 09 February 2016
Matthew L. Handford & Manoj Srinivasan

Robotic lower limb prostheses can improve the quality of life for amputees. Development of
such devices, currently dominated by long prototyping periods, could be sped up by predictive
simulations. In contrast to some amputee simulations which track experimentally determined
non-amputee walking kinematics, here, we explicitly model the human-prosthesis interaction to
produce a prediction of the user’s walking kinematics. We obtain simulations of an amputee using an
ankle-foot prosthesis by simultaneously optimizing human movements and prosthesis actuation,
minimizing a weighted sum of human metabolic and prosthesis costs. The resulting Pareto optimal
solutions predict that increasing prosthesis energy cost, decreasing prosthesis mass, and allowing
asymmetric gaits all decrease human metabolic rate for a given speed and alter human kinematics.
The metabolic rates increase monotonically with speed. Remarkably, by performing an analogous
optimization for a non-amputee human, we predict that an amputee walking with an appropriately
optimized robotic prosthesis can have a lower metabolic cost – even lower than assuming that the
non-amputee’s ankle torques are cost-free.

People with trans-tibial (below knee) amputation commonly use passive prostheses providing some stiffness and
damping (e.g., SACH-foot, Flex-foot1). However, passive prosthesis users experience reduced mobility2,3 and
increased metabolic cost4,5 compared to non-amputees. This reduced performance is partially due to reduced
foot control and an inability to produce net positive work with the prosthesis. Robotic ankle-foot prostheses
could address these issues6,7. Although many robotic prostheses exist, designing and testing new prostheses takes
considerable time: computational simulations could shorten this process. Many previous simulation studies8,9
used human-prosthesis models that tracked non-amputee walking kinematics, thus ignoring human adaptation
to the prosthesis10. Here, rather than assume the amputee’s gait, we seek to predict it. Similarly, rather than assume
a specific prosthesis actuation strategy, we design prosthesis torque profiles through energy optimization.
Numerous studies suggest that humans move in an approximately energy optimal manner11,12, even with
amputation13 or using unpracticed motions14. Here, we use large-scale numerical optimization to compute the
energy-optimal walking motions and prosthesis actuations of a human wearing a unilateral robotic prosthesis.
We compute optimal trade-offs between human metabolic and prosthesis torque costs. We show how increasing
prosthesis mass, using passive prostheses, or forcing left-right symmetry increase human costs for a given walking
speed and how increasing speed increases cost. Finally, we predict that optimal prosthesis actuation can reduce
the amputee metabolic cost much below normal human metabolic cost.

Methods
Human-prosthesis model. We consider a sagittal plane model of a unilateral amputee using an ankle-foot
prosthesis (Fig. 1A) with empirically-based properties15,16. The human component has six rigid-body segments:
one head-arms-torso segment, one segment for each thigh, one segment for each shank, and one segment for the
biological foot. There are thirteen uni- or bi-articular muscles with constant moment-arms and Hill-type
force-velocity relationships: eight muscles on the biological (non-prosthesis) side and five on the prosthesis side.
The prosthesis foot is a single rigid-body segment, actuated by an idealized torque motor with no internal

Mechanical and Aerospace Engineering, The Ohio State University, Columbus, USA. Correspondence and requests
for materials should be addressed to M.L.H. (email: [email protected]) or M.S. (email: [email protected])

Scientific Reports | 6:19983 | DOI: 10.1038/srep19983 1


www.nature.com/scientificreports/

A) Proposed biomechanical B) Contact phase sequence for our walk


model of amputee + prosthesis HT00 0T00 0TH0 0THT

glutei iliopsoas
hamstrings rectus
vasti 00HT 000T H00T HT0T

motor gastroc
tibialis anterior
1-link soleus
prosthesis

foot-ground contact points

Figure 1. (A) A sagittal-plane rigid-body model, with six human body segments and one prosthesis segment,
connected via revolute joints. The leg without amputation uses eight muscles (iliopsoas, gluteus, hamstring,
rectus femorus, vastus lateralis, gastrocnemius, soleus, and tibialis anterior); the leg with amputation uses
identical muscles but removing and replacing all muscles crossing the ankle with a single prosthesis torque
motor at the ankle. (B) Contact phase sequence for a natural walking motion. The four letter code refers to the
points contacting the ground; heel and toe of the biological and prosthetic foot with 0 signifying no contact.

dynamics. The prosthetic foot mass and inertia properties are identical to the human foot unless otherwise stated.
See Supplementary Information for parameter values. We present all parameters and results in non-dimensional
form, normalized by combinations of body mass Mbody, leg length leg , and gravitational acceleration g.
The feet can contact the ground at their heel and toe. We assume a normal walking motion with a prescribed
sequence of eight ‘contact phases’ (Fig. 1B), each denoted by a four-letter code specifying which heels (H) and
toes (T) are in contact or not (0): the first two letters refer to the biological foot’s contact points and the last
two letters refer to the prosthesis’. e.g., HT0T has biological heel and toe and prosthesis toe in contact. Contact
kinematic constraints are imposed using a differential-algebraic formalism, as opposed to modeling contact
with springs and dampers16–18. By assuming that any point in contact with the ground has a zero velocity, this
method of imposing contact constraints removes high frequency and fast time-scale dynamics that can arise due
to springs and dampers. Given muscle forces and prosthesis torque as functions of time and initial conditions
for body state, we can integrate the equations of motion for each contact phase to simulate the motion of the
human-prosthesis system. We model transitions between contact phases as continuous when contact is broken
and as perfectly-inelastic collisions, with velocity changing instantaneously when contact is made.

Energy cost functions. We seek a periodic walking motion that minimizes C , a weighted sum of the human
metabolic cost Cmet and the prosthesis cost Cpros over a stride as follows:

C = (λC met + (1 − λ) C pros )/ T stride (1)

where Tstride is the stride time and 0 ≤  λ ≤  1 is a fixed weighting factor: λ =  1 makes C identical to human cost and
λ =  0 gives the prosthesis cost. Optimizing with multiple λ values allows us to determine the trade-offs between
human metabolic cost and prosthesis cost by changing the relative importance of the two costs in the
optimization.
Our human metabolic cost function is adapted from Alexander and Minetti11,19:
T stride  
C met = ∫0 ∑ [ψ (ai ) + ai φ (v i ) ] F iso,i v max,i  dt ,

 i

 (2)
an integral over the whole stride period and a sum over all muscles, depending on activation ai, shortening veloc-
ity vi, maximum shortening velocity vmax,i, and maximum isometric force Fiso,i; ψ(ai) is an activation-related cost
and φ (v i ) is a function11 describing the metabolic dependence on normalized muscle shortening velocity
v i = v i / v max ,i (3)
(see Supplementary Information, Figure S2). The prosthesis cost is modeled as
T stride
C pros = ∫0 [ (τ / r)2 + ε (τ / r)2 ] dt , (4)

Scientific Reports | 6:19983 | DOI: 10.1038/srep19983 2


www.nature.com/scientificreports/

where τ is the motor torque, τ is the torque-rate, and r is a scaling constant (equal to typical muscle moment arm);
the torque-squared term is a model of motor electrical losses20 and the torque-rate-squared term with a small
pre-multiplier (ε =  0.01) is used to model torque production limitations by penalizing rapid activation and
deactivation11,21.

Other metabolic cost models. While all the results in the main manuscript are based on the above cost
functions for the human and the prosthesis, we also considered two other simple cost functions that have previ-
ously been used in biomechanics to model “effort” or metabolic cost: (1) cost rate for each muscle proportional
to muscle-force squared16,22, and (2) energy cost for each muscle proportional to a weighted sum of positive and
negative work, scaled by the efficiencies of positive and negative work11,23. We did not use other more complex
models based on muscle heat generation18,24, as they are often non-smooth; we will consider such functions in
future work.

Optimization structure and constraints. We seek an optimal walking gait with the periodic contact
phase sequence in Fig. 1B, parameterized using a “multiple-shooting method”. We constrained speed at
v =  1.3 m/s or non-dimensional speed v = v / g leg = 0.42, except for one set of calculations that varied speed
systematically. The eight contact phases, Nphases =  8, each with unknown time duration, are divided into Nseg =  6
time-segments, each with Nunknowns =  32 unknowns (initial conditions for all body segment positions and veloci-
ties and unknown muscle forces and prosthesis motor torque, assumed piecewise linear), producing 1544
unknowns through:
N phases + N phases N unknowns N seg = N total – unknowns (5)
to be determined by optimization. We constrain positions, velocities, forces and torques to be continuous across
different time segments. For collisional transitions, the results of the collision equations (applied to the end of
the contact phase) are equal to the initial conditions for the next contact phase. Further nonlinear constraints
include ground clearance for swing legs, ground contact for stance legs, muscle force-velocity dependence, and
range of motion bounds. We solve the constrained optimization problem using sparse nonlinear programming
(SNOPT11), with equality constraint satisfaction of 10−7. Since it is possible for the optimization to converge to
non-global local minima, we only consider solutions which can be discovered from multiple initial seeds.

Results
Optimizing just the human cost (mostly). We minimized the composite cost C strongly weighted
towards human cost (λ =  0.95), to obtain optima when prosthesis cost is mostly neglected. Figure 2A,B and the
walking animations (Supplementary Video V1) show the corresponding optimal motion is asymmetric.
Setting λ =  1 caused convergence issues in the numerical optimization; presumably because this limit λ =  1
implies a truly “zero cost prosthesis,” the optimization tended to explore large and erratic prosthesis motor tor-
ques and torque rates, resulting in the numerical difficulties.

Comparison with non-amputee gait. We minimized the same human metabolic cost for a non-amputee
(able-bodied) human with symmetric legs and musculature, giving a symmetric optimal gait (Fig. 2A,B).
Metabolic cost for the amputee with a prosthesis is lower than that for the non-amputee (Fig. 3A). The muscles
crossing a single ankle contribute 41% of the optimized non-amputee metabolic cost. Thus, if ideal motor tor-
ques replaced all muscles crossing one ankle while maintaining identical kinematics, the human cost could be
reduced by 41% by this “muscle replacement strategy”. Remarkably, for λ =  0.95, the human cost with a unilateral
prosthesis is 73% lower than the non-amputee cost. This greater cost reduction arises from allowing amputee
kinematics to be different from non-amputee kinematics, thus allowing the prosthesis ankle motor to perform
much more work than the replaced ankle muscles. This is remarkable because while the replaced ankle muscles
provide torques at both ankle and knee (some muscles are biarticular), our prosthesis produces torques only at
the ankle. Thus, extrapolating this trend, we speculate that if we made the prosthesis provide torques at the knee
(simulating a supplementary knee exoskeleton) as well as at the ankle, perhaps the optimal cost reduction might
be even greater.

Optimal trade-offs between human and prosthesis cost. By optimizing with different λ’s between
0.1 and 0.95, we obtain the optimal cost trade-off between human and prosthesis costs (Fig. 3A). This trade-off
curve, often called a “Pareto curve”25, shows that increasing prosthesis cost decreases human cost. Here, even
though obtained by minimizing a weighted sum of human and prosthesis cost, the Pareto curve (if ‘convex’)
also has the following interpretation: this curve gives the lowest human cost for a given prosthesis cost and vice
versa. Any other walking strategy will have either a higher human cost or a higher prosthesis cost compared to
every point on this Pareto curve. Figure 3B shows that the the optimal prosthesis actuation has most of prosthesis
action at the end of stance phase, providing large push-off power; the human cost is reduced through an increase
in prosthesis push-off torque and impulse. While the trade-off in Fig. 3A is specific to the assumed human and
prosthesis costs, we find that almost identical trade-off curves arise when substantially different cost functions are
used (Figure S3, Supplementary Information).

Symmetry is expensive. Every Pareto-optimal gait we found was asymmetric irrespective of λ. However,
walking symmetry is said to have physiological and psychological benefits to prosthesis users26, so we repeated
the optimizations while requiring approximate left-right symmetric kinematics. Symmetry was enforced as a
constraint requiring the left leg joint angles and angular rates during one step be nearly equal to (within 0.05 rad
or 0.05 rads−1 of) the right leg joint angles and angular rates one step later. The resulting symmetric optimal gaits

Scientific Reports | 6:19983 | DOI: 10.1038/srep19983 3


www.nature.com/scientificreports/

Amputee with prosthesis Amputee with prosthesis


A)
(without symmetry contraint) (with symmetry contraint) Non-amputee (able-bodied)

-0.5 0 0.5 1.0 1.5 -0.5 0 0.5 1.0 1.5 -0.5 0 0.5 1.0 1.5
B) Joint Angles: Hip Joint Angles: Knee Joint Angles: Ankle
4 1.5 0.5

3.5 1 0

3 0.5 -0.5

2.5 0 -1
0 0.5 1 0 0.5 1 0 0.5 1
Fraction of gait period Fraction of gait period Fraction of gait period

Amputee, Amputee,
Legend: Able-bodied
asymmetric symmetric

Figure 2. (A) Optimal gait kinematics for amputee walking (with and without symmetry constraint) with
λ =  0.95 and non-amputee walking. For the amputee, the blue leg represents the prosthesis and the black leg
represents the biological one. (B) Optimal joint angles for all three conditions over one gait cycle with periods
of 2.876 (asymmetric), 2.412 (symmetric), and 2.857 (non-amputee). See Supplementary Video V1 for a video
animation of these optimized walking motions.

Figure 3. (A) Optimal trade-offs (Pareto curves) between human and prosthesis costs: without symmetry constraint
(blue line) and with symmetry (red line). Different markers (legend) denote results from different λ’s (0.1–0.95).
Optima from passive prostheses are shown for four non-dimensional stiffnesses (gray dashed line, K1 =   0.1, K2 =   0.5,
K3 =   1.0, K4 =  1.5), as are non-amputee optimum (green line) and the non-amputee optimum (green dotted line) with
muscle replacement strategy (cost-free ankle muscle costs). See Figure S3 (Supplementary Information) for analogous
Pareto trade-off curves for two other metabolic cost models. (B) Prosthesis torque over one stride with gait symmetry
unconstrained and constrained. Each line represents an optimization with different λ (0.1–0.95). The labels ‘swing’
and ‘stance’ are left without a clear demarcation of when these phases occur, because they are different durations for
the different optimal gaits when asymmetry is allowed; with symmetry, each of these phases is 50% of the gait period.

Scientific Reports | 6:19983 | DOI: 10.1038/srep19983 4


www.nature.com/scientificreports/

A) Human-Prosthesis cost trade-off for different prosthesis masses B) Human-Prosthesis cost trade-off for different speeds
0.20
0.16
Relative prosthesis foot mass mpros/mfoot Walking speed (m/s) Cost weighting
0.16
factor, λ

Human metabolic rate

Human metabolic rate


0.12 0.5 0.75 1.0 1.25 1.5 0.7 0.9 1.1 1.3 1.5
0.9
0.12
0.08
0.08

0.04
0.04
0.1

0
0 0.1 0.2 0
0 0.05 0.10 0.15 0.20 0.25
Prosthesis cost rate Prosthesis cost rate

Figure 4. (A) Pareto curves between human and prosthesis cost for five different prosthetic foot masses. Lower
prosthetic foot mass is better. (B) Pareto curves with five different walking speeds. Lower speeds have lower
costs.

had much higher human and prosthesis costs (Fig. 3A) for each λ, a longer push-off phase, and different timing
for dorsiflexion torques during swing phase (Fig. 3B). When we compared the cost of the optimal symmetric gait
at λ =  0.95 to the non-amputee condition, we found only a 27% reduction in the metabolic cost. This reduction in
cost is smaller than the 41% metabolic cost reduction achieved by the replacement strategy. The optimal symmet-
ric gait with the prosthesis is worse than the simple replacement strategy, even though the replacement strategy
would also result in a symmetric gait; while we do not know the reason for these relative costs, presumably the
optimal symmetric gait with the prosthesis has a higher cost because it is unable to replace the knee torques with
the prosthesis (no Gastrocnemius), requiring other muscles to compensate.

Lighter feet are less expensive. We performed optimizations with prosthetic foot masses from 50%–150%
that of the intact foot, scaling the prosthesis moments of inertia similarly. Figure 4A shows that by fixing either
the human or the prosthesis cost, we can reduce the other by reducing prosthesis mass. Further, we see that cost
reductions from reducing foot mass are much smaller than those obtained by increasing the prosthesis cost. Both
human and prosthesis costs seem well-approximated by a linear dependence on the prosthesis mass for each λ
(Figure S4, Supplementary Information), but the coefficients of the linear fit depends on λ.

Greater human cost reduction at higher speeds. We performed optimizations with five different walk-
ing speeds between 0.7 and 1.5 m/s, computing the Pareto curves with λ =  0.1–0.9. As is true for non-amputee
walking, the human metabolic rate increases with increasing speed (Fig. 4B). In particular, the whole Pareto curve
for a lower speed is below and to the left of that for a higher speed, implying that for a given Prosthesis cost rate, a
lower speed implies a lower human metabolic rate and vice versa. Further, we see that for lower speeds, we predict
lower percentage and absolute reduction to the human metabolic rate while using an optimal active prosthesis
with most human benefit (here λ =  0.9).

Passive prosthesis. We performed optimizations constraining the prosthesis to be a linear torsional


spring and damper, simulating a passive prosthesis. We considered four stiffnesses: 0.10, 0.50, 1.00 and
1.50 non-dimensional stiffness normalized by bodyweight, chosen to roughly capture the torque-angle
relationship of optima derived earlier. Damping was chosen to make the foot over-damped during swing; we used
Bpros = 1.73 ⋅ 2 I prosK pros , where Bpros is the damping, Ipros is the prosthesis moment of inertia, Kpros is the tor-
sional stiffness, and 2 I pros K pros is the critical damping value for a second order linear system. While the meta-
bolic cost decreases as the stiffness increased, all of these passive devices produced asymmetric and metabolically
expensive human gaits (Fig. 3A). Human cost with the passive device is comparable to active prosthesis with a
symmetry constraint, except for high λ’s. Thus, the symmetry constraint is so detrimental as to make active
robotic prostheses have little to no energetic benefit over passive devices.

Discussion
We have obtained the optimal tradeoffs between human and prosthesis costs for a robotic unilateral prosthesis,
and have suggested that we can reduce amputee metabolic cost by increasing prosthesis effort, allowing asymme-
try and decreasing prosthesis mass. These relationships can inform prosthesis design, e.g., by selecting a desired
metabolic cost, we could predict the prosthesis cost at various prosthesis masses; the prosthesis torques and costs
along with information on number of steps walked daily will allow us to pick motor and battery specifications for
the prosthesis. We have created a design tool that translates a specification of the level of assistance to be provided
by the prosthesis (namely, λ) into appropriate prosthesis torque profiles.
We have not compared predicted human kinematics and performance with experiment. Such comparison
requires implementing our optimal actuation in a prosthesis; a simpler comparison might involve using a pas-
sive prosthesis in experiment and comparing with the corresponding model-derived optimal human kinematics.
Highly accurate prediction of even non-amputee walking kinematics in a wide variety of novel situations remains

Scientific Reports | 6:19983 | DOI: 10.1038/srep19983 5


www.nature.com/scientificreports/

an open problem; recent attempts have fallen short of quantitatively predicting the correct kinematics, kinetics,
and/or metabolic costs16–18, even though having qualitatively similar kinematics, analogous to our non-amputee
optimization here. Improved predictions of human walking with a prosthesis may require more complex human
body models, more accurate metabolic cost models, and inclusion of other objectives such as lowered interaction
forces between human and prosthesis.
Our optimization predicts asymmetric gaits for both robotic and passive prostheses but the mechanism that
causes the asymmetry is likely different in these two settings. When using a passive prosthesis, the gait becomes
asymmetric since the prosthesis cannot add positive work to the system and the human is compensating with the
intact limb. However, for robotic prostheses, our model suggests asymmetric gaits are energy optimal with sym-
metric gaits costing vastly more. In these asymmetric optimal gaits, the leg with the prosthesis spends more time
on the ground (higher duty factor, Figure S5, Supplementary Information) compared to the biological leg, allow-
ing the robotic prosthesis to provide greater assistance; we predict that optimal prosthesis actuation could reduce
the human cost, possibly much below non-amputee levels (by over 70%). This energy reduction prediction is con-
siderably higher than observed in experimental studies, which have at best reduced the users’ metabolic costs to
about equal to non-amputee metabolic cost27 (about 14% reduction compared to the subjects’ passive prostheses).
This discrepancy in energy costs is likely because our predictions are based on simultaneous optimization of
human and prosthesis control and therefore a best case scenario, whereas the controllers in current robotic pros-
theses are not generally optimized to the person and the person may also not have had enough time to adapt to
the prosthesis. Our optimal prosthesis actuation as a function of time has a large torque impulse near the end of
the stance phase; it may be that current robotic prostheses, with their simpler ankle-state-based feedback control-
lers, are unable to allow the prosthesis to produce a large torque impulse right at the end. Most current prosthesis
also have a lower peak torque than allowed in our simulations, as our peak torque was based on a recent physical
prosthesis emulator28, reported as having the higher torque output among current prostheses. Further, whereas
our prosthesis actuation is specific to walking at a particular speed on level ground, the feedback controllers in
current robotic prostheses may have been the result of compromises made for use at different walking speeds,
slopes, etc. Producing large energy reductions in experiment may require a prosthesis capable of optimizing its
torque output to the person and the environment (perhaps over a training period). Other issues that compound
the discrepancy in costs between current prostheses and our predictions include secondary goals sought by the
user (e.g. gait symmetry, pain reduction, lateral-stability, etc.), or other un-modeled effects.
Alternatively, it may be that the large energy reduction we predict is due to our specific metabolic cost model.
Experimental studies in non-amputees suggest that each ankle contributes about 13% of the metabolic cost of
walking29 while our metabolic cost model predicts a total of 41%. Repeating the non-amputee calculation with
a work-based metabolic cost, we found that only about 18% of the total work cost is due to one ankle – this
is the reduction predicted by a muscle replacement strategy for this work-based cost (Figure S3 and Table S5,
Supplementary Information). For this work-based cost, the robotic prosthesis (with λ =  0.95) produced only
a 23% reduction in cost, still greater than the 18% from the muscle replacement strategy, but much lower than
73%. On the other hand, for a scaled muscle-force-squared cost, the ankle contribution was about 43% for
a non-amputee walk and the reduction from the robotic prosthesis was about 74% (Figure S3 and Table S5,
Supplementary Information). Thus, it appears that some of these specific numerical predictions may rely on the
metabolic cost model and may be improved with a much more accurate metabolic cost model, which remains an
open problem11,18.
Having performed over a hundred different optimization calculations under different parameter conditions
(in contrast to other optimization-based studies16–18), we have demonstrated feasibility of using such large-scale
optimizations in a formal design procedure with user-specific model parameters. Future work could consider
the effects of different prosthesis structures (including non-ideal actuators and passive elements) and constrain-
ing the prosthesis torque to be a function of system state rather than be allowed to vary arbitrarily in time: for
instance, by using existing controller structures found in other prostheses or by parameterizing a torque versus
ankle angle relation for a gait and optimizing the controller parameters. Such additions will allow us to compare
the results of our simulation to those found through experiment, and improve the model to make accurate quan-
titative predictions.

References
1. Lehmann, J. et al. Comprehensive analysis of energy storing prosthetic feet: Flex foot and seattle foot versus standard sach foot. Arch.
Phys. Med. Rehabil. 74, 1225–1231 (1993).
2. Burger, H., Marincek, C. & Isakov, E. Mobility of persons after traumatic lower limb amputation. Disabil. Rehabil. 19, 272–277
(1997).
3. Davies, B. & Datta, D. Mobility outcome following unilateral lower limb amputation. Prosthet. Orthot. Int. 27, 186–190 (2003).
4. Ganguli, S., Datta, S., Chatterjee, B. & Roy, B. Metabolic cost of walking at different speeds with patellar tendon-bearing prosthesis.
J. Appl. Physiol. 36, 440–443 (1974).
5. Waters, R., Perry, J., Antonelli, D. & Hislop, H. Energy cost of walking of amputees: the influence of level of amputation. J. Bone Joint
Surg. Am. 58, 42–46 (1976).
6. Au, S., Weber, J. & Herr, H. Powered ankle-foot prosthesis improves walking metabolic economy. IEEE Trans. Robot. 25, 51–66
(2009).
7. Caputo, J. & Collins, S. Prosthetic ankle push-off work reduces metabolic rate but not collision work in non-amputee walking. Sci.
Rep. 4, 51–66, doi: 10.1038/srep07213 (2014).
8. Zmitrewicz, R., Neptune, R. & Sasaki, K. Mechanical energetic contributions from individual muscles and elastic prosthetic feet
during symmetric unilateral transtibial amputee walking: a theoretical study. J. Biomech. 40, 1824–1831 (2007).
9. LaPre, A., Umberger, B. & Sup, F. Simulation of a powered ankle prosthesis with dynamic joint alignment. In Conf. Proc. IEEE Eng.
Med. Biol. Soc. 1618–1621 (2014).
10. Mattes, S., Martin, P. E. & Royer, T. Walking symmetry and energy cost in persons with unilateral transtibial amputations: matching
prosthetic and intact limb inertial properties. Arch. Phys. Med. Rehabil. 81, 561–568 (2000).

Scientific Reports | 6:19983 | DOI: 10.1038/srep19983 6


www.nature.com/scientificreports/

11. Srinivasan, M. Fifteen observations on the structure of energy minimizing gaits in many simple biped models. J. R. Soc. Interface. 8,
74–98 (2011).
12. Alexander, R. Optimization and gaits in the locomotion of vertebrates. Physiol. Rev. 69, 1199–1227 (1989).
13. Ralston, H. Energy-speed relation and optimal speed during level walking. Int. Z. Angew. Physiol. 17, 277–283 (1958).
14. Handford, M. & Srinivasan, M. Sideways walking: preferred is slow, slow is optimal, and optimal is expensive. Biol. Lett. 10,
20131006 (2014).
15. Gerritsen, K., van den Bogert, A., Hulliger, M. & Zernicke, R. Intrinsic muscle properties facilitate locomotor control - a computer
simulation study. Motor Control 2, 206–220 (1998).
16. Ackermann, M. & van den Bogert, A. J. Optimality principles for model-based prediction of human gait. J. Biomech. 43, 1055–1060
(2010).
17. Anderson, F. C. & Pandy, M. G. Dynamic optimization of human walking. J. Biomech. Eng. 123, 381–390 (2001).
18. Miller, R. H. A comparison of muscle energy models for simulating human walking in three dimensions. J. Biomech. 47, 1373–1381
(2014).
19. Minetti, A. & Alexander, R. A theory of metabolic costs for bipedal gaits. J. Theor. Biol. 186, 467–476 (1997).
20. Bhounsule, P. A. et al. Low-bandwidth reflex-based control for lower power walking: 65 km on a single battery charge. Int. J. Robot
Res. 33, 1305–1321 (2014).
21. Rebula, J. R. & Kuo, A. D. The cost of leg forces in bipedal locomotion: A simple optimization study. PLOS ONE 10, e0117384,
doi: 10.1371/journal.pone.0117384 (2015).
22. Martin, A. E. & Schmiedeler, J. P. Predicting human walking gaits with a simple planar model. J. Biomech. 47, 1416–1421 (2014).
23. Srinivasan, M. & Ruina, A. Computer optimization of a minimal biped model discovers walking and running. Nature 439, 72–75
(2006).
24. Umberger, B. R. Stance and swing phase costs in human walking. J. Roy. Soc. Interface 7, 1329–1340 (2010).
25. Marler, R. & Arora, J. Survey of multi-objective optimization methods for engineering. Struct. Multidiscip. O. 26, 369–395 (2004).
26. Nolan, L. et al. Adjustments in gait symmetry with walking speed in trans-femoral and trans-tibial amputees. Gait Posture 17,
142–151 (2003).
27. Herr, H. & Grabowski, A. Bionic ankle-foot prosthesis normalizes walking gait for persons with leg amputation. Proc. R. Soc. B. 279,
457–464 (2012).
28. Caputo, J. & Collins, S. A universal ankle-foot prosthesis emulator for human locomotion experiments’. J. Biomech. Eng. 136, 035002
(2014).
29. Sawicki, G. S. & Ferris, D. P. Powered ankle exoskeletons reveal the metabolic cost of plantar flexor mechanical work during walking
with longer steps at constant step frequency. J. Exp. Biol. 212, 21–31 (2009).

Acknowledgements
This work was supported by the NSF CMMI grant 1300655. Thanks to Joshua Caputo and Steven Collins (CMU)
for extensive conversations informing this work.

Author Contributions
M.L.H. created the human-prosthesis model and performed the optimizations, in discussion with M.S., M.L.H.
and M.S. wrote the paper together.

Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Handford, M. L. and Srinivasan, M. Robotic lower limb prosthesis design through
simultaneous computer optimizations of human and prosthesis costs. Sci. Rep. 6, 19983; doi: 10.1038/srep19983
(2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images
or other third party material in this article are included in the article’s Creative Commons license,
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this
license, visit http://creativecommons.org/licenses/by/4.0/

Scientific Reports | 6:19983 | DOI: 10.1038/srep19983 7

You might also like